share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR

福泰製藥 | 4：持股變動聲明-高管 WAGNER CHARLES F JR
美股sec公告 ·  06/06 04:18
牛牛AI助理已提取核心訊息
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
致富金融(臨時代碼)執行長兼首席財務官 Charles F. Wagner Jr. (VRTX) 於2024年6月3日出售了3,250股普通股，每股價格為460.00美元，總售價為1,495,000美元。此次交易後，瓦格納在該公司的直接持股數為47,137股普通股。此次交易是通過公開市場交易進行的，如該公司的最新申報所述。
致富金融(臨時代碼)執行長兼首席財務官 Charles F. Wagner Jr. (VRTX) 於2024年6月3日出售了3,250股普通股，每股價格為460.00美元，總售價為1,495,000美元。此次交易後，瓦格納在該公司的直接持股數為47,137股普通股。此次交易是通過公開市場交易進行的，如該公司的最新申報所述。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。